Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$82,690,000
Lobbying expense
—
Federal awards
—
Relationships
500
| $480,000 |
| — |
| lobbied by | Inc. Amgen | $440,000 | — |
| lobbied by | Inc. Alexion Pharmaceuticals | $400,000 | — |
| lobbied by | Inc. Amgen | $400,000 | — |
| lobbied by | Inc. Alexion Pharmaceuticals | $390,000 | — |
| lobbied by | Inc. Netlist | $360,000 | — |
| lobbied by | Pmi Us Corporate Services Inc. | $360,000 | — |
| lobbied by | Biotechnology Innovation Organization | $360,000 | — |
| lobbied by | Genentech Inc | $360,000 | — |
| lobbied by | Inc. Novo Nordisk | $340,000 | — |
| lobbied by | Astrazeneca Pharmaceuticals Lp | $320,000 | — |
| lobbied by | Inc. Amgen | $320,000 | — |
| lobbied by | Inc. Amgen | $320,000 | — |
| lobbied by | Bristol-Myers Squibb Company | $320,000 | — |
| lobbied by | Synthetic Biology Coalition | $300,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $300,000 | — |
| lobbied by | Adult Vaccine Access Coalition | $300,000 | — |
| lobbied by | Genentech Inc | $300,000 | — |
| lobbied by | Hospice Compassus | $300,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $300,000 | — |
| lobbied by | Biotechnology Innovation Organization | $300,000 | — |
| lobbied by | The Orthoforum | $300,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $300,000 | — |
| lobbied by | Inc. Johnson & Johnson Services | $300,000 | — |
| lobbied by | Alnylam Pharmaceuticals, Inc. | $300,000 | — |
| lobbied by | Inc. Alkermes | $300,000 | — |
| lobbied by | Pmi Us Corporate Services Inc. | $300,000 | — |
| lobbied by | Celgene Corporation | $290,000 | — |
| lobbied by | Inc. Alexion Pharmaceuticals | $280,000 | — |
| lobbied by | Bristol-Myers Squibb Company | $280,000 | — |
| lobbied by | Med Claims Compliance Corporation | $280,000 | — |
| lobbied by | Synthetic Biology Coalition | $270,000 | — |
| lobbied by | Medical Countermeasures Coalition | $260,000 | Apr 20, 2026 – Jul 21, 2026 |
| lobbied by | Apollo Global Management | $260,000 | — |
| lobbied by | Inc. Horizon Therapeutics Usa | $250,000 | — |
| lobbied by | Inc. Exelixis | $250,000 | — |
| lobbied by | Bayer Corporation | $250,000 | — |
| lobbied by | Inc. Alkermes | $250,000 | — |
| lobbied by | Inc. Otsuka America Pharmaceutical | $250,000 | — |
| lobbied by | Bayer Corporation | $250,000 | — |
| lobbied by | Inc. Gilead Sciences | $250,000 | — |
| lobbied by | Avs Bio | $250,000 | — |
| lobbied by | Inc. Emd Serono | $250,000 | — |
| lobbied by | Inc. Emd Serono | $250,000 | — |
| lobbied by | McKesson Corporation | $250,000 | — |
| lobbied by | The Coalition For 21st Century Medicine | $250,000 | — |
| lobbied by | Ginkgo Biosecurity | $250,000 | — |